InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,827.52
(
0.21%
)
US TECH 100
19,600.40
(
-0.17%
)
Dow Jones
42,987.33
(
0.58%
)
Brent Oil
74.06
(
-0.56%
)
Bitcoin
67,622.10
(
0.92%
)
Post# of 253380
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rhaab

Send PM Follow Ignore
Followers 1
Posts 55
Boards Moderated 0
Alias Born 10/29/2005

rhaab

Re: drbio45 post# 41265

Tuesday, 01/30/2007 5:17:30 PM

Tuesday, January 30, 2007 5:17:30 PM

Post# of 253380
YM BioSciences announces termination of the tesmilifene Phase III pivotal trial in advanced breast cancer

http://www.cnxmarketlink.com/en/releases/archive/January2007/30/c2871.html

The Data Safety Monitoring Board advises the trial is very unlikely to demonstrate a survival benefit for the tesmilifene arm

Conference call scheduled for Wednesday, January 31, 8:30 a.m. ET
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up